{"schema_version":"secwatch.filing_event.v1","accession":"0001062993-25-017390","form_type":"8-K","ticker":"INM","cik":"0001728328","company_name":"InMed Pharmaceuticals Inc.","filed_at":"2025-12-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.268410+00:00","generated_at":"2026-05-16T12:45:44.901596+00:00","sec_items":["5.07","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"InMed shareholders re-elect all five directors, approve auditor and share issuance at AGM","bullets":["All five director nominees elected with 81.9% to 82.1% support.","Appointment of CBIZ CPAs P.C. as auditor for 2026 approved (78.8% for).","Shareholders approved potential issuance of >=20% of shares under SEPA with YA II PN (65.9% for).","Turnout was 993,491 shares (35.43% of outstanding)."],"urls":{"canonical":"https://secwatch.observer/filing/0001062993-25-017390","json":"https://secwatch.observer/filing/0001062993-25-017390.json","markdown":"https://secwatch.observer/filing/0001062993-25-017390.md","text":"https://secwatch.observer/filing/0001062993-25-017390.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1728328/000106299325017390/0001062993-25-017390-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1728328/000106299325017390/form8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T12:45:44.901596+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}